IJR News — today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Ask Genius
Apps
News
Home
Popular
Explore
Library
Play
Start a journal
Ask Genius
Apps
Trending
ADAR1 Capital Expands Biotech Portfolio Across Five Stocks
x/adenosine-deaminase-rna-specific
— Aug 25, 2026
ADAR1 Capital Management LLC disclosed new positions in five biopharma names in Q2, including sizable buys of ACADIA Pharmaceuticals, Adagio Medical, Larimar Therapeutics, Artiva Biotherapeutics, and Corvus Pharmaceuticals, with investment values ranging from roughly $785,000 to over $1.9 million. The ACADIA stake coincides with the European Commission’s approval of DAYBU for Rett syndrome, signaling potential expansion into a key EU market for the company.
+43
Share